Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07011394Recruiting

Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation

Role: collaborator

NCT06981169Recruiting

PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

Role: collaborator

NCT07309614Phase 3Recruiting

A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

Role: collaborator

NCT06985628Not ApplicableCompleted

Alleviating Dyspnea With Non-Invasive Neuromodulation

Role: collaborator

NCT05992519Completed

Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma

Role: collaborator

NCT05870215Completed

Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma Attacks

Role: collaborator

All 6 trials loaded